| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,560,003 | 1,397,057 | 1,250,865 | 1,276,172 | | Cost of Revenue | 1,267,124 | 1,135,075 | 997,324 | 1,010,371 | | | Gross Profit | 292,879 | 261,982 | 253,541 | 265,801 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 105,108 | 100,507 | 89,446 | 99,069 | | Non Recurring | 3,940 | (3,276) | (664) | (663) | | Others | 41,857 | 39,953 | 39,940 | 34,382 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 144,734 | 124,798 | 124,819 | 133,013 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,777 | 12,509 | 7,348 | 113,077 | | Earnings Before Interest And Taxes | 176,805 | 151,495 | 153,389 | 171,285 | | Interest Expense | 50,371 | 50,888 | 50,908 | 43,375 | | Income Before Tax | 126,434 | 100,607 | 102,481 | 127,910 | | Income Tax Expense | 4,729 | 3,068 | 2,871 | 5,632 | | Minority Interest | (232) |
-
|
-
| (73) | | | | Net Income From Continuing Ops | 176,937 | 97,539 | 99,610 | 122,205 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 121,473 | 97,539 | 99,610 | 122,205 | | Preferred Stock And Other Adjustments | 20 | (1) | (19) | (22,764) | | | Net Income Applicable To Common Shares | $121,493 | $97,538 | $99,591 | $99,441 |
|
0.50% Nasdaq 
0.08 (0.14%) 
Income Statement
